Harrow

Harrow Net Debt per Share

The Net Debt per Share of Harrow (HROW) as of Oct 15, 2026 is 4.63 USD. In the previous year, Net Debt per Share was 4.69 USD — a change of -1.18% (lower).

Net Debt per Share

4.63USD

YoY

-1.18%

Last updated:

Net Debt per Share of Harrow is 2025 4.63 USD. Net Debt per Share of Harrow was 2024 4.69 USD. It decreases by -1.18% lower compared to the previous year.

The Harrow Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2018
-0.35 USD
Jan 1, 2019
-0.43 USD
Jan 1, 2020
-0.45 USD
Jan 1, 2021
0.57 USD
Jan 1, 2022
0.22 USD
Jan 1, 2023
2.73 USD
Jan 1, 2024
4.69 USD
Jan 1, 2025
4.63 USD
The Harrow Net Debt per Share history
YEARNet Debt per ShareYoY
4.63USD-1.18%
4.69USD+71.60%
2.73USD+1,166.15%
0.22USD-62.29%
0.57USD-227.87%
-0.45USD+3.12%
-0.43USD+24.04%
-0.35USD-213.98%
0.31USD+132.74%
0.13USD-20.74%
0.17USD-175.39%
-0.22USD—
Access this data via the Eulerpool API

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harrow stock

Net Debt per Share of Harrow is 4.63 USD in 2025.

Net Debt per Share of Harrow changed from 4.69 USD to 4.63 USD, representing a -1.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Harrow since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

Other — Harrow

All Key Metrics — Harrow